Xeris Biopharma Holdings, Inc.
XERS · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $621 | -$1,928 | -$9,220 | -$5,113 |
| Dep. & Amort. | $3,049 | $2,918 | $3,143 | $3,133 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $7,643 | $5,008 | $4,443 | $3,595 |
| Change in WC | $0 | -$6,882 | -$9,241 | -$474 |
| Other Non-Cash | $7,119 | $1,066 | $844 | $834 |
| Operating Cash Flow | $18,432 | $182 | -$10,031 | $1,975 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$363 | $13 | -$13 | -$220 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $10,236 |
| Other Inv. Act. | $292 | -$292 | $0 | $0 |
| Investing Cash Flow | -$71 | -$279 | -$13 | $10,016 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $830 | $0 | $0 | $0 |
| Stock Repurch. | -$9,336 | $7,998 | -$7,998 | -$166 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $13,850 | $0 | $4,861 | $564 |
| Financing Cash Flow | $13,850 | $942 | -$3,137 | $398 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $0 | $845 | -$13,181 | $12,389 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $59,285 | $58,440 | $75,744 | $63,355 |
| End Cash | $0 | $59,285 | $62,563 | $75,744 |
| Free Cash Flow | $18,069 | $10,044 | -$10,044 | $1,755 |